Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 24, 2026
Why Is FedEx Corporation (FDX) Stock Down -7.5% Today?

Why Is FedEx Corporation (FDX) Stock Down -7.5% Today?

Key Takeaways

  • FDX shares are down approximately 7.50% in premarket trading on Wednesday, June 24, 2026, despite the company reporting better-than-expected fourth-quarter fiscal 2026 revenue and earnings.
  • The primary catalyst for the decline is fiscal year 2027 EPS guidance of approximately $17.50 at the midpoint, which missed Wall Street consensus estimates by roughly 7.4%, triggering a "sell the news" reaction.
  • Q4 FY2026 operating margin came in at 6.2%, down 1.9 percentage points year over year, raising questions about the profitability of the core delivery business following the spin-off of FedEx Freight on June 1, 2026.
  • The forward earnings outlook also reflects uncertainty about how the newly standalone FedEx — without its high-margin trucking division — will perform under the company's Network 2.0 integration strategy.
  • The broader logistics and transportation sector did not experience a comparable broad selloff, isolating the move as earnings-driven and specific to FedEx.
  • Traders are watching for analyst commentary on post-spin-off margin recovery and whether management's 11% revenue growth assumption for fiscal 2027 holds up.

Opening Summary

FedEx Corporation (FDX) is one of the world's largest logistics and transportation companies, providing express delivery, ground shipping, freight, and supply chain services to customers in more than 220 countries and territories. On June 1, 2026, FedEx completed the spin-off of its trucking division, FedEx Freight, into an independent publicly traded company (FDXF), making Q4 FY2026 the last quarter to include freight segment contributions.

FDX closed Tuesday's regular session at $328.78, before plunging in after-hours and into premarket trading on Wednesday to approximately $304.13 — a decline of approximately $24.65, or 7.50%, from the prior close. Despite headline-level earnings beats on both revenue and adjusted EPS, investors focused instead on a below-consensus fiscal 2027 earnings outlook and margin compression in the core delivery operations, triggering a sharp post-earnings selloff.

Earnings Beat, Guidance Miss

FedEx delivered Q4 FY2026 results that topped Wall Street expectations on nearly every top-line metric. Total revenue came in at $25.0 billion, surpassing the analyst consensus of approximately $24.01–$24.3 billion and representing 12.5% year-over-year growth. Adjusted EPS of $6.31 beat the Street estimate of $5.92 by approximately 6.6%, while GAAP diluted EPS of $6.60 also exceeded consensus.

However, the market's reaction turned sharply negative on the forward guidance. FedEx issued fiscal year 2027 adjusted EPS guidance of approximately $16.90–$18.10, with the midpoint of roughly $17.50 coming in approximately 7.4% below analyst consensus estimates. That guidance miss effectively offset the earnings beat, as investors recalibrated expectations for how profitable the newly leaner FedEx will be without its high-margin freight division contributing to consolidated results. Management cited anticipated 11% revenue growth for FY2027 — including three percentage points from fuel surcharges — but the earnings-per-share shortfall against expectations proved the more decisive market signal.

Margin Compression After Freight Spin-Off

Underlying the guidance disappointment is a structural margin concern. In Q4 FY2026, FedEx reported a GAAP operating margin of 6.2%, down 1.9 percentage points from the same quarter a year earlier. On an adjusted basis, the operating margin came in at approximately 8.35%, narrowly missing the analyst forecast of 8.44%. While management positioned the results as reflecting the transitional costs of separating the freight business and completing the Network 2.0 integration overhaul, investors interpreted the margin figures as evidence that the core Express and Ground segments face a more challenging profitability path than anticipated.

The FedEx Freight spin-off — which had been widely expected to be a long-term value unlock — is now raising short-term concerns about whether the remaining business can sustain, let alone expand, its operating margins. The trucking unit was a consistent profit contributor, and its removal from the consolidated income statement creates a higher bar for the delivery segments to carry. FedEx's longer-term multi-year strategy targets an operating margin of 8% by 2029, but the Q4 results and FY2027 guidance suggest that gap will take longer to close than some had modeled.

Market Context and Trading Activity

The earnings-driven selloff in FDX unfolded against a backdrop of broadly stable broader market conditions, underscoring that the decline is a company-specific reaction to the earnings report rather than a macro or sector-level event. Logistics peers and transportation ETFs did not reflect comparable moves, further isolating the catalyst.

Trading volume in Tuesday's regular session was elevated ahead of the after-hours earnings release. The extended-hours reaction was swift and significant, with FDX falling sharply in after-hours and carrying that momentum into Wednesday's premarket. From a technical standpoint, the move pushes FDX back toward the mid-$290s–low-$300s range, retracing a portion of the gains accumulated ahead of the report. The 52-week low of $242.83 remains well below current premarket levels, though the deterioration in forward guidance may prompt sell-side analysts to revise price targets downward in the sessions ahead.

Trending AI Robots

For traders navigating post-earnings volatility in large-cap names like FDX, Tickeron provides a broad suite of AI-powered trading tools designed for systematic, data-driven decision-making. With hundreds of AI bots covering thousands of tickers across multiple strategies and timeframes, the platform offers tools suited to a wide range of market environments. Rather than listing every available bot, Tickeron curates a dedicated Trending AI Robots page that highlights only those bots delivering the strongest performance under current market conditions. Each featured bot is assessed on its strategy type, performance metrics, traded symbols, and risk profile. Investors and active traders seeking a structured way to complement their own earnings analysis may find the Trending AI Robots section a useful resource for navigating today's tape.

What Comes Next for FDX

The near-term focus for FDX will center on analyst reactions to the fiscal 2027 guidance range in the days following Tuesday's earnings call. Multiple sell-side firms are expected to revise their models and price targets to reflect both the below-consensus EPS midpoint and the updated margin trajectory for the post-freight-spinoff business. Analyst commentary from firms including Stifel — which noted that the results "highlight the effectiveness" of the multi-lever transformation strategy — will be weighed against the headline guidance shortfall.

The first full quarter as a freight-free company will be Q1 FY2027, with results expected in approximately September 2026. That report will be the first clean read on how the Express and Ground segments perform without the trucking unit, and it will be a key test of whether FedEx's cost-reduction and Network 2.0 optimization efforts are translating into margin recovery. Macro variables including global trade volumes, fuel price trends, e-commerce demand cycles, and the ongoing impact of international trade policy shifts will also factor into investor expectations for FDX in the second half of calendar 2026.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: FDX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


FDX in +1.85% Uptrend, advancing for three consecutive days on October 02, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FDX advanced for three days, in 234 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FDX's RSI Indicator exited the oversold zone, 12 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 61 cases where FDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

FDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for FDX turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 28 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

FDX moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FDX crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

The Aroon Indicator for FDX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.166) is normal, around the industry mean (3.756). P/E Ratio (15.615) is within average values for comparable stocks, (222.905). Projected Growth (PEG Ratio) (1.224) is also within normal values, averaging (5.110). Dividend Yield (0.018) settles around the average of (0.013) among similar stocks. P/S Ratio (0.761) is also within normal values, averaging (2.034).

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. FDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 57 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are United Parcel Service (NYSE:UPS), FedEx Corp (NYSE:FDX), C.H. Robinson Worldwide (NASDAQ:CHRW).

Industry description

Other Transportation includes transportation services like providing airport ground transportation, airport management and equipment, shipping services, as well as businesses that operate bridges, expressways and other public services such as taxis and subways. Grupo Aero-pac, Corporacion America Airports S.A. and Matson, Inc. are some of the major companies operating in this space.

Market Cap

The average market capitalization across the Other Transportation Industry is 8.15B. The market cap for tickers in the group ranges from 414.67K to 80.19B. UPS holds the highest valuation in this group at 80.19B. The lowest valued company is JETR at 414.67K.

High and low price notable news

The average weekly price growth across all stocks in the Other Transportation Industry was 1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -19%. SGLY experienced the highest price growth at 17%, while HXHX experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Other Transportation Industry was 58%. For the same stocks of the Industry, the average monthly volume growth was 120% and the average quarterly volume growth was 29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 51
Price Growth Rating: 65
SMR Rating: 79
Profit Risk Rating: 88
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
FDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

provider of a broad portfolio of transportation, e-commerce and business services under the FedEx brand

Industry OtherTransportation

Industry
Air Freight Or Couriers
Address
942 South Shady Grove Road
Phone
+1 901 818-7500
Employees
530000
Web
https://www.fedex.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.